Memantine Accord

Memantine, the active ingredient in Memantine Accord, is a non‑competitive NMDA receptor antagonist presented as an oral tablet for systemic use. It is employed in the symptomatic management of moderate to severe Alzheimer’s disease, helping to improve cognition, function and behavior in adult patients.

GNH USA supplies Memantine Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing for regulated markets and ensuring consistent quality across regions.

Memantine acts on the glutamatergic pathway to provide symptomatic relief in neurodegenerative disease.

Alzheimer's disease: improves cognitive function, daily living activities and behavioral symptoms in patients with moderate to severe disease.

Memantine is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Dizziness: transient light‑headedness, especially at treatment initiation. - Headache: mild to moderate intensity, often resolves with continued use. - Constipation: reduced bowel movements, manageable with diet. - Fatigue: feeling unusually tired or weak.

Serious or Rare Side Effects: - Seizures: rare occurrence, requires immediate medical attention. - Cardiac arrhythmia: irregular heart rhythm, monitor in patients with cardiac disease. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic injury: elevated liver enzymes or hepatitis. - Suicidal thoughts: new or worsening mood changes, report promptly. - Severe rash: widespread or blistering skin eruption.

When prescribing Memantine, clinicians should consider several safety aspects. - Renal function: adjust dose in patients with impaired clearance. - Seizure history: monitor closely as the drug may lower seizure threshold. - Cardiovascular disease: assess risk of arrhythmias, especially with concomitant QT‑prolonging agents. - Hepatic impairment: use with caution; monitor liver enzymes. - Concomitant medications: review for potential interactions that may increase adverse effects. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Memantine may interact with several medicines, requiring vigilance.

Major Interactions (Avoid): - Amantadine or other NMDA antagonists: additive neuro‑psychiatric effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): increase memantine plasma levels. - High‑dose NSAIDs: heightened risk of edema and hypertension.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: may reduce cognitive benefit of memantine. - Diuretics or antihypertensives: monitor blood pressure and electrolyte balance.